These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10362445)

  • 1. Methamphetamine-associated obsessional symptoms and effective risperidone treatment: a case report.
    Iyo M; Sekine Y; Matsunaga T; Tsukamoto T; Takei N; Mori N
    J Clin Psychiatry; 1999 May; 60(5):337-8. PubMed ID: 10362445
    [No Abstract]   [Full Text] [Related]  

  • 2. Risperidone treatment of methamphetamine psychosis.
    Misra L; Kofoed L
    Am J Psychiatry; 1997 Aug; 154(8):1170. PubMed ID: 9247413
    [No Abstract]   [Full Text] [Related]  

  • 3. Risperidone as monotherapy for a patient with obsessive compulsive disorder comorbid with schizoaffective disorder: a case report.
    Chiou YJ; Lin PY; Lee Y
    Clin Neuropharmacol; 2015; 38(3):114-6. PubMed ID: 25970281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination of risperidone and serotonergic antidepressants in refractory obsessive-compulsive disorder].
    Salmerón JM; Alcántara AG; Barcia D
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(6):399-402. PubMed ID: 9972593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obsessive-compulsive disorder followed by psychotic episode in long-term ecstasy misuse.
    Marchesi C; Tonna M; Maggini C
    World J Biol Psychiatry; 2009; 10(4 Pt 2):599-602. PubMed ID: 17853269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exacerbation of psychosis by phenylpropanolamine.
    Goodhue A; Bartel RL; Smith NB
    Am J Psychiatry; 2000 Jun; 157(6):1021-2. PubMed ID: 10831490
    [No Abstract]   [Full Text] [Related]  

  • 7. Serotonin syndrome from fluvoxamine and buspirone.
    Baetz M; Malcolm D
    Can J Psychiatry; 1995 Sep; 40(7):428-9. PubMed ID: 8548727
    [No Abstract]   [Full Text] [Related]  

  • 8. Obsessive-compulsive symptoms associated with clozapine and risperidone treatment: three case reports and review of the literature.
    Ke CL; Yen CF; Chen CC; Yang SJ; Chung W; Yang MJ
    Kaohsiung J Med Sci; 2004 Jun; 20(6):295-301. PubMed ID: 15253471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of inhalant abuse with risperidone.
    Misra LK; Kofoed L; Fuller W
    J Clin Psychiatry; 1999 Sep; 60(9):620. PubMed ID: 10520984
    [No Abstract]   [Full Text] [Related]  

  • 10. [Minocycline as a therapeutic drug for methamphetamine use disorders].
    Hashimoto K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Feb; 28(1):19-22. PubMed ID: 18411705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoniazid-Induced Psychosis with Obsessive-Compulsive Symptoms (Schizo-Obsessive Disorder) in a Female Child.
    Baytunca MB; Erermis S; Bildik T; Kayahan B
    J Child Adolesc Psychopharmacol; 2015 Dec; 25(10):819-20. PubMed ID: 25265091
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to "Risperidone-induced obsessive-compulsive symptoms: serotonin-dopamine imbalance?".
    Alevizos B; Lykouras L; Zervas IM; Christodoulou GN
    J Clin Psychopharmacol; 2004 Oct; 24(5):549. PubMed ID: 15349015
    [No Abstract]   [Full Text] [Related]  

  • 13. Brief report: two-year control of behavioral symptoms with risperidone in two profoundly retarded adults with autism.
    Dartnall NA; Holmes JP; Morgan SN; McDougle CJ
    J Autism Dev Disord; 1999 Feb; 29(1):87-91. PubMed ID: 10097998
    [No Abstract]   [Full Text] [Related]  

  • 14. [Toxic drug-induced psychoses].
    Medvecký J; Durindová Z
    Cesk Psychiatr; 1971 Apr; 67(2):98-103. PubMed ID: 5554021
    [No Abstract]   [Full Text] [Related]  

  • 15. The 5-HT2 receptor profiles of antipsychotics in the pathogenesis of obsessive-compulsive symptoms in schizophrenia.
    Kim SW; Shin IS; Kim JM; Youn T; Yang SJ; Hwang MY; Yoon JS
    Clin Neuropharmacol; 2009; 32(4):224-6. PubMed ID: 19644229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic psychotic illness from methamphetamine.
    Buffenstein A; Heaster J; Ko P
    Am J Psychiatry; 1999 Apr; 156(4):662. PubMed ID: 10200757
    [No Abstract]   [Full Text] [Related]  

  • 17. [Methamphetamine, cannabis].
    Naruse N
    Nihon Rinsho; 2015 Sep; 73(9):1481-6. PubMed ID: 26394507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.
    Sekine Y; Iyo M; Ouchi Y; Matsunaga T; Tsukada H; Okada H; Yoshikawa E; Futatsubashi M; Takei N; Mori N
    Am J Psychiatry; 2001 Aug; 158(8):1206-14. PubMed ID: 11481152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone in treatment of choreoathetosis of Huntington's disease.
    Parsa MA; Szigethy E; Voci JM; Meltzer HY
    J Clin Psychopharmacol; 1997 Apr; 17(2):134-5. PubMed ID: 10950488
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors for treatment-resistive methamphetamine psychosis.
    Fujii D
    J Neuropsychiatry Clin Neurosci; 2002; 14(2):239-40. PubMed ID: 11983802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.